Financial News
Press Releases about Natera Inc
From Natera, Inc.
Via Business Wire
Natera Announces Real-World Data Collaboration with Merck
November 14, 2023
From Natera, Inc.
Via Business Wire
Natera Reports Third Quarter 2023 Financial Results
November 08, 2023
From Natera, Inc.
Via Business Wire
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
November 08, 2023
From Natera, Inc.
Via Business Wire
Natera to Participate in November Investor Conferences
November 07, 2023
From Natera, Inc.
Via Business Wire
Natera to Report its Third Quarter 2023 Results on November 8
October 20, 2023
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
Natera Submits First PMA Module to the FDA for Signatera™
October 02, 2023
From Natera, Inc.
Via Business Wire
Natera Announces Senior Leadership Appointments
September 18, 2023
From Natera, Inc.
Via Business Wire
Natera Announces Pricing of $250 Million Follow-On Offering
September 07, 2023
From Natera, Inc.
Via Business Wire
Natera to Participate in Upcoming Investor Conferences
September 01, 2023
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
Natera Reports Second Quarter 2023 Financial Results
August 03, 2023
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.